Scholars Central

Review articlePublished 5 Nov 2024

Glycobiology-Targeted Therapies in Hematologic Oncology: Ushering in a New Era of Cancer Diagnostics and Therapeutics

Authors: Ashraf Abdullah Saad

Journal of Glycobiology

Volume 13 · Issue 6 · Pages 1–92

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Despite that immunotherapy revolutionized cancer treatment, a considerable proportion of patients do not respond. While scientists continued to make perpetuating efforts in order to associate, glycans (carbohydrates) have come under scrutiny as the next frontier in pharmaceutical research. Immunologically speaking, tumor specific glycan signatures that mediate tumor cell recognition by the immune system offer novel immunotherapy targets for developing both specific and powerful therapeutic strategies against cancer. Notwithstanding that we are lately witnessing breakthrough discoveries in glycan-targeting therapies for solid tumors being reported in a substantial number of studies, the utilization of these therapies in liquid tumors (i.e., leukemia, lymphoma and myeloma) continued to lag far behind. On the other hand, humoral and cellular immunotherapeutic agents were quite successful in selected hematologic malignancies, albeit patients with Relapsed/Refractory (R/R) disease and those crippled by financial and/or drug toxicities remain extremely disadvantaged. Between the currently employed immunotherapeutic modalities and the Overall Survival (OS) rate, the full potential of glyco-oncology creates a divide that must be continuously researched and bridged. Therefore, this review aims to contextualize the glycosylation landscape of liquid tumors within the field of hematologic oncology in order to establish ‘Glycobiology in Hematology’ as a new emerging paradigm in cancer research and therapeutics.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Glycobiology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Glycobiology
  • SubjectOncology & Cancer
  • SubjectHaematology
  • BylineArticles whose byline prints “Ashraf Abdullah Saad”